INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 98 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $4,000 | +33.3% | 777 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -62.5% | 777 | 0.0% | 0.00% | – |
Q3 2018 | $8,000 | +33.3% | 777 | 0.0% | 0.00% | – |
Q2 2018 | $6,000 | +20.0% | 777 | 0.0% | 0.00% | – |
Q1 2018 | $5,000 | -54.5% | 777 | -33.5% | 0.00% | – |
Q4 2017 | $11,000 | +10.0% | 1,168 | 0.0% | 0.00% | – |
Q3 2017 | $10,000 | -68.8% | 1,168 | -53.4% | 0.00% | – |
Q2 2017 | $32,000 | -23.8% | 2,506 | -36.9% | 0.00% | – |
Q1 2017 | $42,000 | -90.2% | 3,972 | -91.5% | 0.00% | -100.0% |
Q4 2016 | $428,000 | -65.5% | 46,496 | -55.9% | 0.00% | -75.0% |
Q3 2016 | $1,242,000 | -30.8% | 105,331 | -24.0% | 0.00% | -20.0% |
Q2 2016 | $1,794,000 | +3.2% | 138,643 | +27.6% | 0.01% | 0.0% |
Q1 2016 | $1,738,000 | +320.8% | 108,691 | +652.2% | 0.01% | +400.0% |
Q4 2015 | $413,000 | +41200.0% | 14,449 | +288880.0% | 0.00% | – |
Q3 2015 | $1,000 | -100.0% | 5 | -100.0% | 0.00% | -100.0% |
Q1 2015 | $3,430,000 | +334.7% | 59,000 | +210.0% | 0.01% | +233.3% |
Q1 2014 | $789,000 | +23.5% | 19,034 | +15.3% | 0.00% | +50.0% |
Q4 2013 | $639,000 | – | 16,502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADVANTAGE INVESTMENT MANAGEMENT, LLC | 105 | $0 | 0.00% |
Sterling Investment Advisors, Ltd. | 250 | $0 | 0.00% |
Front Row Advisors LLC | 60 | $0 | 0.00% |
Executive Wealth Management, LLC | 20 | $0 | 0.00% |
BARCLAYS PLC | 1,300 | $0 | 0.00% |
BARCLAYS PLC | 33,172 | $10,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Financial Gravity Asset Management, Inc. | 50 | $0 | 0.00% |
Vectors Research Management, LLC | 505 | $0 | 0.00% |